Glenmark Life Sciences Limited IPO (Glenmark Life Sciences IPO) Detail

Jul 27, 2021 - Jul 29, 2021

Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.

Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.

Competitive strengths

  • Leading manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS, diabetes, and pain management.
  • Export products in Europe, Latin America, North America, Japan, and the rest of the world.
  • Strong relationship with leading global generic companies.
  • Proven track record of strong financial performance.
  • High-quality product manufacturing with R&D infrastructure.

Company Promoters:

Glenmark Pharmaceuticals Limited is the promoter of the company.

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92

Objects of the Issue:

  • To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
  • To finance capital expenditure requirements.
  • To meet general corporate purposes.

Glenmark Life Sciences IPO Details

IPO Opening DateJul 27, 2021
IPO Closing DateJul 29, 2021
Issue TypeBook Built Issue IPO
Face Value₹2 per equity share
IPO Price₹695 to ₹720 per equity share
Market Lot20 Shares
Min Order Quantity20 Shares
Listing AtBSE, NSE
Issue Size[.] Eq Shares of ₹2
(aggregating up to ₹1,513.60 Cr)
Fresh Issue[.] Eq Shares of ₹2
(aggregating up to ₹1,060.00 Cr)
Offer for Sale6,300,000 Eq Shares of ₹2
(aggregating up to ₹453.60 Cr)

Glenmark Life Sciences IPO Tentative Timetable

The Glenmark Life Sciences IPO open date is Jul 27, 2021, and the close date is Jul 29, 2021. The issue may list on Aug 6, 2021.

IPO Open DateJul 27, 2021
IPO Close DateJul 29, 2021
Basis of Allotment DateAug 3, 2021
Initiation of RefundsAug 4, 2021
Credit of Shares to Demat AccountAug 5, 2021
IPO Listing DateAug 6, 2021

Glenmark Life Sciences IPO Lot Size

The Glenmark Life Sciences IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹187,200).

ApplicationLotsSharesAmount (Cut-off)
Minimum120₹14,400
Maximum13260₹187,200

Glenmark Life Sciences IPO Promoter Holding

Pre Issue Share Holding100%
Post Issue Share Holding82.84%

Glenmark Life Sciences IPO Subscription Status (Bidding Detail)

The Glenmark Life Sciences IPO is subscribed 44.17x times on Jul 29, 2021 17:01. The public issue subscribed 14.63x in the retail category, 36.97x in the QIB category, and 122.54x in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryIPO Subscription
QIB

36.97x

NII

122.54x

RII

14.63x

Total

44.17x

Note: Glenmark Life Sciences IPO application wise subscription: 11 times

Glenmark Life Sciences IPO Prospectus

Glenmark Life Sciences IPO Rating

3021
4.2
Rating:Rated 4.2 stars

Vote Here ...

Glenmark Life Sciences IPO Registrar

KFintech Private Limited
   KFintech, Tower-B, Plot No 31 & 32,
   Financial District, Nanakramguda, Gachibowli,
   Hyderabad, Telangana India - 500 032.

Phone: 04067162222, 04079611000
Email: glenmark.ipo@kfintech.com
Website: https://karisma.kfintech.com/

Glenmark Life Sciences IPO FAQs

  1. What is Glenmark Life Sciences IPO?

    Glenmark Life Sciences IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹1,513.60 Crores. The issue is priced at ₹695 to ₹720 per equity share. The minimum order quantity is 20 Shares.

    The IPO opens on Jul 27, 2021, and closes on Jul 29, 2021.

    KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

  2. How to apply in Glenmark Life Sciences IPO through Zerodha?

    Zerodha customers can apply online in Glenmark Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Glenmark Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.

    Steps to apply in Glenmark Life Sciences IPO through Zerodha

    1. Visit the Zerodha website and login to Console.
    2. Go to Portfolio and click the IPOs link.
    3. Go to the 'Glenmark Life Sciences IPO' row and click the 'Bid' button.
    4. Enter your UPI ID, Quantity, and Price.
    5. ‘Submit’ IPO application form.
    6. Visit the UPI App (net banking or BHIM) to approve the mandate.

    Visit Zerodha IPO Application Process Review for more detail.

  3. When Glenmark Life Sciences IPO will open?

    The Glenmark Life Sciences IPO opens on Jul 27, 2021 and closes on Jul 29, 2021.

  4. What is the lot size of Glenmark Life Sciences IPO?

    Glenmark Life Sciences IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.

  5. How to apply for Glenmark Life Sciences IPO?

    You can apply in Glenmark Life Sciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

  6. When Glenmark Life Sciences IPO allotment?

    The finalization of Basis of Allotment for Glenmark Life Sciences IPO will be done on Aug 3, 2021, and the allotted shares will be credited to your demat account by Aug 5, 2021. Check the Glenmark Life Sciences IPO allotment status.

  7. When is Glenmark Life Sciences IPO listing date?

    The Glenmark Life Sciences IPO listing date is not yet announced. The tentative date of Glenmark Life Sciences IPO listing is Aug 6, 2021.

Glenmark Life Sciences IPO Message Board

Ranked Members  Ranked Members

Loading...







Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App